Have a feature idea you'd love to see implemented?
Let us know!
MEDP Medpace Holdings Inc
Price (delayed)
$341.82
Market cap
$10.62B
P/E Ratio
28.89
Dividend/share
N/A
EPS
$11.83
Enterprise value
$10.1B
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate
Highlights
Medpace Holdings's quick ratio has surged by 102% YoY and by 13% QoQ
Medpace Holdings's equity has soared by 87% YoY and by 15% from the previous quarter
Key stats
What are the main financial stats of MEDP
Market
Valuations
Earnings
Shares outstanding
31.08M
Market cap
$10.62B
Enterprise value
$10.1B
Price to earnings (P/E)
28.89
Price to book (P/B)
12.02
Price to sales (P/S)
5.12
EV/EBIT
24.4
EV/EBITDA
21.72
EV/Sales
4.88
Revenue
$2.07B
EBIT
$413.79M
EBITDA
$464.88M
Free cash flow
$535.65M
Per share
Balance sheet
Liquidity
EPS
$11.83
Free cash flow per share
$17.25
Book value per share
$28.43
Revenue per share
$66.7
TBVPS
$44.67
Total assets
$2.08B
Total liabilities
$1.2B
Debt
$128.28M
Equity
$881.44M
Working capital
-$8.76M
Debt to equity
0.15
Current ratio
0.99
Quick ratio
0.93
Net debt/EBITDA
-1.14
Margins
Efficiency
Dividend
EBITDA margin
22.4%
Gross margin
29.7%
Net margin
17.7%
Operating margin
19.7%
Return on assets
19.6%
Return on equity
50.9%
Return on invested capital
N/A
Return on capital employed
39.7%
Return on sales
20%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MEDP stock price
How has the Medpace Holdings stock price performed over time
Intraday
4.82%
1 week
2.08%
1 month
-3.15%
1 year
23.73%
YTD
11.51%
QTD
2.4%
Financial performance
How have Medpace Holdings's revenue and profit performed over time
Revenue
$2.07B
Gross profit
$614.79M
Operating income
$408.81M
Net income
$365.67M
Gross margin
29.7%
Net margin
17.7%
The net income has increased by 34% YoY and by 8% from the previous quarter
The operating income has increased by 25% year-on-year and by 7% since the previous quarter
MEDP's gross profit is up by 22% year-on-year and by 6% since the previous quarter
MEDP's revenue is up by 16% year-on-year and by 2% since the previous quarter
Growth
What is Medpace Holdings's growth rate over time
Valuation
What is Medpace Holdings stock price valuation
P/E
28.89
P/B
12.02
P/S
5.12
EV/EBIT
24.4
EV/EBITDA
21.72
EV/Sales
4.88
The EPS is up by 34% YoY and by 7% QoQ
The P/E is 17% lower than the last 4 quarters average of 34.7 and 8% lower than the 5-year quarterly average of 31.3
Medpace Holdings's equity has soared by 87% YoY and by 15% from the previous quarter
MEDP's price to book (P/B) is 24% lower than its last 4 quarters average of 15.9 but 6% higher than its 5-year quarterly average of 11.3
MEDP's revenue is up by 16% year-on-year and by 2% since the previous quarter
MEDP's price to sales (P/S) is 10% less than its last 4 quarters average of 5.7 but 7% more than its 5-year quarterly average of 4.8
Efficiency
How efficient is Medpace Holdings business performance
The company's return on equity fell by 26% YoY and by 8% QoQ
The ROS is up by 10% YoY and by 5% QoQ
Dividends
What is MEDP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MEDP.
Financial health
How did Medpace Holdings financials performed over time
The company's total assets is 73% higher than its total liabilities
Medpace Holdings's quick ratio has surged by 102% YoY and by 13% QoQ
Medpace Holdings's current ratio has surged by 87% YoY and by 13% QoQ
The debt is 85% smaller than the equity
Medpace Holdings's equity has soared by 87% YoY and by 15% from the previous quarter
MEDP's debt to equity has dropped by 50% year-on-year and by 12% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.